期刊论文详细信息
RGUHS Journal of Pharmaceutical Sciences
Sustained Ocular Delivery of Sparfloxacin from pH Triggered In Situ Gelling System
Mohammed Gulzar Ahmed1  K. Sowmya Reddy1 
[1] Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, B.G. Nagar, Karnataka - 571448. India.Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, B.G. Nagar, Karnataka - 571448. India.Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, B.G. Nagar, Karnataka - 571448. India.
关键词: In situ;    Sparfloxacin;    pH trigger;    HPMC;    Carbopol.;   
DOI  :  10.5530/rjps.2014.3.4
学科分类:药学、药理学、毒理学(综合)
来源: Rajiv Gandhi University of Health Sciences
PDF
【 摘 要 】

Purpose-The present research work was to develop and evaluate In Situ gels of Sparfloxacin. Method/approach-In situ gels were prepared by using HPMC and carbopol based on the concept of pH trigger gelation systems.Formulations were evaluated for gelling capacity, drug content, clarity, viscosity and In vitro release. Findings-FTIR studies showed that the drug and excipients were compatible. Experimental part showed that viscosity of sols was increased with increase in the concentration of polymers and the solutions showed pseudoplastic behaviour. Sol-to-gel transformation occurred in the presence of simulated tear fluid of pH 7.4. The drug content was found satisfactory. The In vitro release profile of Sparfloxacin from the S3 formulation have shown least drug release (72.34 %) in 8 hrs compared to formulation S2 that is 77.30%, the correlation coefficient ‘r’ indicated that the drug release followed diffusion controlled mechanism from the In Situ gels. Sparfloxacin has In vitro activity against a wide range of gram-negative and grampositive microorganisms.The antimicrobial studies against Streptococcus aureus were showed positive results. The formulations were therapeutically efficacious, sterile and provided sustained release of the drug over a period of time. Application/Value-These results demonstrate that the developed system is an alternative to conventional drug delivery system.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201912010225036ZK.pdf 1408KB PDF download
  文献评价指标  
  下载次数:8次 浏览次数:8次